Carnosine is neuroprotective against permanent focal cerebral ischemia in mice

118Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND AND PURPOSE - Carnosine is a naturally occurring dipeptide with multiple neuroprotective properties. In addition, it is well tolerated in high doses with minimal side effects. The purposes of this study were to determine whether carnosine is neuroprotective in permanent focal cerebral ischemia and to determine potential mechanisms of neuroprotection. METHODS - We investigated the efficacy of carnosine in a mouse model of permanent focal cerebral ischemia. The effects of carnosine were investigated with respect to neuronal damage and infarct formation, endogenous antioxidant status, and matrix metalloproteinase activity. RESULTS - Carnosine significantly decreased infarct size and neuronal damage when administered at time points both before and after the induction of ischemia. Carnosine also decreased reactive oxygen species levels in the ischemic brain, preserved normal glutathione levels, and decreased matrix metalloproteinase protein levels and activity. CONCLUSIONS - Carnosine is neuroprotective in focal cerebral ischemia and appears to influence deleterious pathological processes that are activated after the onset of ischemia. © 2007 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Rajanikant, G. K., Zemke, D., Senut, M. C., Frenkel, M. B., Chen, A. F., Gupta, R., & Majid, A. (2007). Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke, 38(11), 3023–3031. https://doi.org/10.1161/STROKEAHA.107.488502

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free